梅花生物：控股股东孟庆山犯操纵证券市场罪，被判有期徒刑三年，缓刑五年

Core Viewpoint - The announcement from Meihua Biological indicates that the company's controlling shareholder, Meng Qingshan, has been convicted of manipulating the securities market, receiving a three-year prison sentence with a five-year probation, along with a fine. However, this matter is stated to be personal and does not affect the company's operations or governance structure [1]. Group 1 - On November 7, Meihua Biological announced that its controlling shareholder, Meng Qingshan, was prosecuted and received a criminal judgment for manipulating the securities market [1]. - Meng Qingshan was sentenced to three years in prison, with a five-year probation, and a fine that will be offset by previously paid administrative penalties [1]. - Since retiring in January 2017, Meng Qingshan has not held any position within the company and only exercises shareholder rights at the shareholder meeting level [1]. Group 2 - The company asserts that the legal issues concerning Meng Qingshan are personal and do not relate to the company itself [1]. - Meihua Biological's production and operational activities are reported to be normal and unaffected by this incident [1]. - The matter is stated to have no impact on the company's equity structure, corporate governance, or operational activities [1].